BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15362369)

  • 1. Defective mismatch-repair colorectal cancer: clinicopathologic characteristics and usefulness of immunohistochemical analysis for diagnosis.
    Jover R; Payá A; Alenda C; Poveda MJ; Peiró G; Aranda FI; Pérez-Mateo M
    Am J Clin Pathol; 2004 Sep; 122(3):389-94. PubMed ID: 15362369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer.
    Plevová P; Krepelová A; Papezová M; Sedláková E; Curík R; Foretová L; Navrátilová M; Novotný J; Zapletalová J; Palas J; Nieslanik J; Horácek J; Dvorácková J; Kolár Z
    Neoplasma; 2004; 51(4):275-84. PubMed ID: 15254659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.
    Marcus VA; Madlensky L; Gryfe R; Kim H; So K; Millar A; Temple LK; Hsieh E; Hiruki T; Narod S; Bapat BV; Gallinger S; Redston M
    Am J Surg Pathol; 1999 Oct; 23(10):1248-55. PubMed ID: 10524526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
    Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
    Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas.
    Wright CL; Stewart ID
    Am J Surg Pathol; 2003 Nov; 27(11):1393-406. PubMed ID: 14576472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective mismatch repair and the development of recurrent endometrial carcinoma.
    Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG
    Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for defective DNA mismatch repair in stage II and III colorectal cancer patients.
    Chai SM; Zeps N; Shearwood AM; Grieu F; Charles A; Harvey J; Goldblatt J; Joseph D; Iacopetta B
    Clin Gastroenterol Hepatol; 2004 Nov; 2(11):1017-25. PubMed ID: 15551255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
    Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
    Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatch repair deficiency in sporadic synchronous colorectal cancer.
    Brueckl WM; Limmert T; Brabletz T; Guenther K; Jung A; Hermann K; Wiest GH; Kirchner T; Hohenberger W; Hahn EG; Wein A
    Anticancer Res; 2000; 20(6C):4727-32. PubMed ID: 11205208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced COX-2 protein in colorectal cancer with defective mismatch repair.
    Karnes WE; Shattuck-Brandt R; Burgart LJ; DuBois RN; Tester DJ; Cunningham JM; Kim CY; McDonnell SK; Schaid DJ; Thibodeau SN
    Cancer Res; 1998 Dec; 58(23):5473-7. PubMed ID: 9850081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1.
    Thibodeau SN; French AJ; Cunningham JM; Tester D; Burgart LJ; Roche PC; McDonnell SK; Schaid DJ; Vockley CW; Michels VV; Farr GH; O'Connell MJ
    Cancer Res; 1998 Apr; 58(8):1713-8. PubMed ID: 9563488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors.
    Lubomierski N; Plotz G; Wormek M; Engels K; Kriener S; Trojan J; Jungling B; Zeuzem S; Raedle J
    Cancer; 2005 Sep; 104(5):952-61. PubMed ID: 16015629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAT-26 microsatellite instability does not correlate with the loss of hMLH1 and hMSH2 protein expression in sporadic endometrial cancers.
    Miturski R; Bogusiewicz M; Tarkowski R; Ciotta C; Bignami M; Burnouf D; Jakowicki JA
    Oncol Rep; 2003; 10(4):1039-43. PubMed ID: 12792767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer.
    Fallik D; Borrini F; Boige V; Viguier J; Jacob S; Miquel C; Sabourin JC; Ducreux M; Praz F
    Cancer Res; 2003 Sep; 63(18):5738-44. PubMed ID: 14522894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies.
    Ricciardiello L; Ceccarelli C; Angiolini G; Pariali M; Chieco P; Paterini P; Biasco G; Martinelli GN; Roda E; Bazzoli F
    Clin Cancer Res; 2005 Jun; 11(11):4234-40. PubMed ID: 15930362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic colorectal cancers with defective mismatch repair display a number of specific morphological characteristics: relationship between the expression of hMLH1 and hMSH2 proteins and clinicopathological features of 273 adenocarcinomas.
    Chapusot C; Martin L; Mungra N; Rageot D; Bouvier AM; Bonithon Kopp C; Ponnelle T; Faivre J; Piard F
    Histopathology; 2003 Jul; 43(1):40-7. PubMed ID: 12823711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer.
    Kitajima Y; Miyazaki K; Matsukura S; Tanaka M; Sekiguchi M
    Gastric Cancer; 2003; 6(2):86-95. PubMed ID: 12861399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the DNA mismatch repair proteins (hMLH1 and hMSH2) in infiltrating pancreatic cancer and its relation to some phenotypic features.
    Tomaszewska R; Okoń K; Stachura J
    Pol J Pathol; 2003; 54(1):31-7. PubMed ID: 12817878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
    Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.